NGFR and Huntington disease: Other small molecules, including those with action at TrkB [236,237], p75NTR [238], and REST [239] have also shown limited beneficial effects in HD models, likely due in part to the partial rescue of BDNF expression or TrkB activity through their pharmacological targets.